SCHEMBL27401397

SCHEMBL27401397

CC(NC(=O)c1ccc2[nH]c(=O)[nH]c2c1)c1ccc2cc[nH]c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.59
TAS1R3 Q7RTX0 2/20 0.53
TAS1R1 Q7RTX1 2/20 0.53
SMYD3 Q9H7B4 3/20 0.48
CTSK P43235 1/20 0.46
IMPDH2 P12268 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
ENPP2 Q13822 1/20 0.44
HSD17B10 Q99714 1/20 0.44
B3GNT2 Q9NY97 3/20 0.43
F10 P00742 2/20 0.43
MAPT P10636 1/20 0.43
MAPK11 Q15759 1/20 0.43
MAPK14 Q16539 1/20 0.43
MAPK1 P28482 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27402732 1.00 PDE2A (0.59) PDE2ATAS1R3TAS1R1SMYD3CTSK
SCHEMBL12658565 0.81 SMYD3 (0.49) SMYD3IMPDH2KDM4EALDH1A1B3GNT2
SCHEMBL27402577 0.80 ALDH1A1 (0.57) PDE2ASMYD3IMPDH2ALDH1A1HPGD
SCHEMBL27402490 0.80 B3GNT2 (0.60) PDE2ATAS1R3TAS1R1SMYD3IMPDH2
SCHEMBL27402731 0.79 SMYD3 (0.46) SMYD3IMPDH2B3GNT2MAPTMAPK11
SCHEMBL27402835 0.78 NR1H4 (0.62) PDE2ASMYD3IMPDH2B3GNT2MAPT
SCHEMBL27400717 0.78 TAS1R3 (0.60) PDE2ATAS1R3TAS1R1IMPDH2ALDH1A1
SCHEMBL19531859 0.77 TAS1R3 (0.68) TAS1R3TAS1R1SMYD3CTSKKDM4E
SCHEMBL27402404 0.77 PDE2A (0.55) PDE2A
SCHEMBL27401308 0.77 PDE2A (0.55) PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024117179-A1 KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF ALIVEXIS, INC. (JP) 2024-06-06 WO disclosed